The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients
Clinical trial NCT04432688 · COMPLETED
Trial details
- NCT number
- NCT04432688
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-03-18
- Enrollment
- 3192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.